RGD-coated polymeric microbubbles promote ultrasound-mediated drug delivery in an inflamed endothelium-pericyte co-culture model of the blood-brain barrier.
Blood-brain barrier
Drug delivery
Microbubbles
Sonopermeation
Ultrasound
Journal
Drug delivery and translational research
ISSN: 2190-3948
Titre abrégé: Drug Deliv Transl Res
Pays: United States
ID NLM: 101540061
Informations de publication
Date de publication:
18 Mar 2024
18 Mar 2024
Historique:
accepted:
22
02
2024
medline:
18
3
2024
pubmed:
18
3
2024
entrez:
18
3
2024
Statut:
aheadofprint
Résumé
Drug delivery to central nervous pathologies is compromised by the blood-brain barrier (BBB). A clinically explored strategy to promote drug delivery across the BBB is sonopermeation, which relies on the combined use of ultrasound (US) and microbubbles (MB) to induce temporally and spatially controlled opening of the BBB. We developed an advanced in vitro BBB model to study the impact of sonopermeation on the delivery of the prototypic polymeric drug carrier pHPMA as a larger molecule and the small molecule antiviral drug ribavirin. This was done under standard and under inflammatory conditions, employing both untargeted and RGD peptide-coated MB. The BBB model is based on human cerebral capillary endothelial cells and human placental pericytes, which are co-cultivated in transwell inserts and which present with proper transendothelial electrical resistance (TEER). Sonopermeation induced a significant decrease in TEER values and facilitated the trans-BBB delivery of fluorescently labeled pHPMA (Atto488-pHPMA). To study drug delivery under inflamed endothelial conditions, which are typical for e.g. tumors, neurodegenerative diseases and CNS infections, tumor necrosis factor (TNF) was employed to induce inflammation in the BBB model. RGD-coated MB bound to and permeabilized the inflamed endothelium-pericyte co-culture model, and potently improved Atto488-pHPMA and ribavirin delivery. Taken together, our work combines in vitro BBB bioengineering with MB-mediated drug delivery enhancement, thereby providing a framework for future studies on optimization of US-mediated drug delivery to the brain.
Identifiants
pubmed: 38498080
doi: 10.1007/s13346-024-01561-6
pii: 10.1007/s13346-024-01561-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Bhalerao A, Sivandzade F, Archie SR, Chowdhury EA, Noorani B, Cucullo L. In vitro modeling of the neurovascular unit: advances in the field, Fluids and Barriers of the CNS, 17 (2020).
Brown LS, Foster CG, Courtney J-M, King NE, Howells DW, Sutherland BA. Pericytes and neurovascular function in the healthy and diseased brain. Front Cell Neurosci, 13 (2019).
Banks WA. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov. 2016;15:275–92.
pubmed: 26794270
doi: 10.1038/nrd.2015.21
Stefan H, Feuerstein TJ. Novel anticonvulsant drugs. Pharmacol Ther. 2007;113:165–83.
pubmed: 17030393
doi: 10.1016/j.pharmthera.2006.07.005
Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier, Advances in Pharmacological Sciences, 2018 (2018).
Rufino-Ramos D, Albuquerque PR, Carmona V, Perfeito R, Nobre RJ. Pereira De Almeida, Extracellular vesicles: novel promising delivery systems for therapy of brain diseases. J Control Release. 2017;262:247–58.
pubmed: 28687495
doi: 10.1016/j.jconrel.2017.07.001
Shi Y, van der Meel R, Chen X, Lammers T. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics. 2020;10:7921–4.
pubmed: 32685029
pmcid: 7359085
doi: 10.7150/thno.49577
Zheng Y, Ma L, Sun Q. Clinically-relevant ABC transporter for Anti-cancer Drug Resistance. Front Pharmacol, 12 (2021).
de Maar JS, Rousou C, van Elburg B, Vos HJ, Lajoinie GPR, Bos C, Moonen CTW, Deckers R. Ultrasound-mediated drug delivery with a clinical Ultrasound System: in vitro evaluation. Front Pharmacol. 2021;12:768436.
pubmed: 34737709
pmcid: 8560689
doi: 10.3389/fphar.2021.768436
Beekers I, Lattwein KR, Kouijzer JJP, Langeveld SAG, Vegter M, Beurskens R, Mastik F, Verduyn Lunel R, Verver E, van der Steen AFW, de Jong N. Kooiman, Combined Confocal Microscope and Brandaris 128 Ultra-high-speed Camera. Ultrasound Med Biol. 2019;45:2575–82.
pubmed: 31262523
doi: 10.1016/j.ultrasmedbio.2019.06.004
Beekers I, Mastik F, Beurskens R, Tang PY, Vegter M, Van Der Steen AFW, De Jong N, Verweij MD, Kooiman K. High-resolution imaging of intracellular calcium fluctuations caused by oscillating Microbubbles. Ultrasound Med Biol. 2020;46:2017–29.
pubmed: 32402676
doi: 10.1016/j.ultrasmedbio.2020.03.029
Beekers I, Vegter M, Lattwein KR, Mastik F, Beurskens R, Van Der Steen AFW, De Jong N, Verweij MD, Kooiman K. Opening of endothelial cell–cell contacts due to sonoporation. J Controlled Release. 2020;322:426–38.
doi: 10.1016/j.jconrel.2020.03.038
Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER Measurement Techniques for in Vitro Barrier Model systems. J Lab Autom. 2015;20:107–26.
pubmed: 25586998
pmcid: 4652793
doi: 10.1177/2211068214561025
Butt AM, Jones HC, Abbott NJ. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J Physiol. 1990;429:47–62.
pubmed: 2277354
pmcid: 1181686
doi: 10.1113/jphysiol.1990.sp018243
Berndt P, Winkler L, Cording J, Breitkreuz-Korff O, Rex A, Dithmer S, Rausch V, Blasig R, Richter M, Sporbert A, Wolburg H, Blasig IE, Haseloff RF. Tight junction proteins at the blood-brain barrier: far more than claudin-5. Cell Mol Life Sci. 2019;76:1987–2002.
pubmed: 30734065
doi: 10.1007/s00018-019-03030-7
Helms HC, Abbott NJ, Burek M, Cecchelli R, Couraud P-O, Deli MA, Förster C, Galla HJ, Romero IA, Shusta EV, Stebbins MJ, Vandenhaute E, Weksler B, Brodin B. In vitro models of the blood–brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metabolism. 2016;36:862–90.
doi: 10.1177/0271678X16630991
Eigenmann DE, Xue G, Kim KS, Moses AV, Hamburger M, Oufir M. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS. 2013;10:33.
pubmed: 24262108
pmcid: 4176484
doi: 10.1186/2045-8118-10-33
Gonzales-Aloy E, Ahmed-Cox A, Tsoli M, Ziegler DS, Kavallaris M. From cells to organoids: the evolution of blood-brain barrier technology for modelling drug delivery in brain cancer. Adv Drug Deliv Rev. 2023;196:114777.
pubmed: 36931346
doi: 10.1016/j.addr.2023.114777
Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32:1959–72.
pubmed: 22929442
pmcid: 3494002
doi: 10.1038/jcbfm.2012.126
de Vries HE, Blom-Roosemalen MCM, Oosten Mv, de Boer AG, van Berkel TJC, Breimer DD, Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol. 1996;64:37–43.
pubmed: 8598388
doi: 10.1016/0165-5728(95)00148-4
Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR, Prat A, Scarpa M, Smeyne RJ, Drewes LR, Neuwelt EA. Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab. 2013;33:13–21.
pubmed: 23072749
doi: 10.1038/jcbfm.2012.153
Loh LC, Locke D, Melnychuk R, Laferté S. The RGD sequence in the cytomegalovirus DNA polymerase accessory protein can mediate cell adhesion. Virology. 2000;272:302–14.
pubmed: 10873773
doi: 10.1006/viro.2000.0366
Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697–715.
pubmed: 8970741
doi: 10.1146/annurev.cellbio.12.1.697
Ludwig BS, Kessler H, Kossatz S, Reuning U. RGD-Binding integrins revisited: how recently discovered functions and Novel Synthetic ligands (Re-)Shape an ever-evolving field. Cancers (Basel), 13 (2021).
Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000;50:184–95.
pubmed: 10891884
doi: 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H
Horton MA. The αvβ3 integrin vitronectin receptor. Int J Biochem Cell Biol. 1997;29:721–5.
pubmed: 9251239
doi: 10.1016/S1357-2725(96)00155-0
Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol. 1996;149:293–305.
pubmed: 8686754
pmcid: 1865227
Singh S, Drude N, Blank L, Desai PB, Königs H, Rütten S, Langen K-J, Möller M, Mottaghy FM, Morgenroth A. Protease responsive nanogels for transcytosis across the blood– brain barrier and intracellular delivery of Radiopharmaceuticals to Brain Tumor cells. Adv Healthc Mater. 2021;10:2100812.
doi: 10.1002/adhm.202100812
Snipstad S, Sulheim E, de Lange Davies C, Moonen C, Storm G, Kiessling F, Schmid R, Lammers T. Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation. Expert Opin Drug Deliv. 2018;15:1249–61.
pubmed: 30415585
doi: 10.1080/17425247.2018.1547279
Koczera P, Appold L, Shi Y, Liu M, Dasgupta A, Pathak V, Ojha T, Fokong S, Wu Z, van Zandvoort M, Iranzo O, Kuehne AJC, Pich A, Kiessling F, Lammers T. PBCA-based polymeric microbubbles for molecular imaging and drug delivery. J Control Release. 2017;259:128–35.
pubmed: 28279799
pmcid: 5528138
doi: 10.1016/j.jconrel.2017.03.006
Marty B, Larrat B, Van Landeghem M, Robic C, Robert P, Port M, Le Bihan D, Pernot M, Tanter M, Lethimonnier F, Mériaux S. Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis. J Cereb Blood Flow Metab. 2012;32:1948–58.
pubmed: 22805875
pmcid: 3463875
doi: 10.1038/jcbfm.2012.100
Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 1998;98:290–3.
pubmed: 9711932
doi: 10.1161/01.CIR.98.4.290
Sassaroli E, Hynynen K. Forced linear oscillations of microbubbles in blood capillaries. J Acoust Soc Am. 2004;115:3235–43.
pubmed: 15237848
doi: 10.1121/1.1738456
Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Volume 11. Angiogenesis; 2008. pp. 109–19.
May JN, Golombek SK, Baues M, Dasgupta A, Drude N, Rix A, Rommel D, von Stillfried S, Appold L, Pola R, Pechar M, van Bloois L, Storm G, Kuehne AJC, Gremse F, Theek B, Kiessling F, Lammers T. Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation. Theranostics. 2020;10:1948–59.
pubmed: 32042346
pmcid: 6993230
doi: 10.7150/thno.41161
Shen Y, Guo J, Chen G, Chin CT, Chen X, Chen J, Wang F, Chen S, Dan G. Delivery of liposomes with different sizes to mice Brain after Sonication by Focused Ultrasound in the Presence of Microbubbles. Ultrasound Med Biol. 2016;42:1499–511.
pubmed: 27126236
doi: 10.1016/j.ultrasmedbio.2016.01.019
Wang S, Hossack JA, Klibanov AL. Targeting of microbubbles: contrast agents for ultrasound molecular imaging. J Drug Target. 2018;26:420–34.
pubmed: 29258335
pmcid: 6319889
doi: 10.1080/1061186X.2017.1419362
Dasgupta A, Sun T, Rama E, Motta A, Zhang Y, Power C, Moeckel D, Fletcher S-M, Moosavifar M, Barmin R, Porte C, Buhl EM, Bastard C, Pallares RM, Kiessling F, McDannold N, Mitragotri S, Lammers T. Transferrin Receptor-Targeted Nonspherical Microbubbles for Blood–Brain Barrier Sonopermeation, Advanced Materials, n/a 2308150.
De Lorenzi F, Hansen N, Theek B, Daware R, Motta A, Breuel S, Nasehi R, Baumeister J, Schöneberg J, Stojanović N. Engineering Mesoscopic 3D tumor models with a Self-Organizing Vascularized Matrix. Adv Mater, (2023) 2303196.
De Lorenzi NHF, Theek B, Daware R, Motta A, Breuel S, Nasehi R, Baumeister J. Jan Schöneberg, Natalija Stojanović, Saskia Von Stillfried, Michael Vogt, Gerhard Müller-Newen, Jochen Maurer, Alexandros Marios Sofias, Twan Lammers, Horst Fischer, Fabian Kiessling, Engineering Mesoscopic 3D tumor models with a Self-Organizing Vascularized Matrix. Advanced Materials; 2023.
Boitsova EB, Morgun AV, Osipova ED, Pozhilenkova EA, Martinova GP, Frolova OV, Olovannikova RY, Tohidpour A, Gorina YV, Panina YA, Salmina AB. The inhibitory effect of LPS on the expression of GPR81 lactate receptor in blood-brain barrier model in vitro. J Neuroinflammation. 2018;15:196.
pubmed: 29973231
pmcid: 6030740
doi: 10.1186/s12974-018-1233-2
Hollmann EK, Bailey AK, Potharazu AV, Neely MD, Bowman AB, Lippmann ES. Accelerated differentiation of human induced pluripotent stem cells to blood–brain barrier endothelial cells. Fluids Barriers CNS. 2017;14:9.
pubmed: 28407791
pmcid: 5390351
doi: 10.1186/s12987-017-0059-0
Canfield SG, Stebbins MJ, Morales BS, Asai SW, Vatine GD, Svendsen CN, Palecek SP, Shusta EV. An isogenic blood–brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells. J Neurochem. 2017;140:874–88.
pubmed: 27935037
pmcid: 5339046
doi: 10.1111/jnc.13923
Fokong S, Siepmann M, Liu Z, Schmitz G, Kiessling F, Gätjens J. Advanced characterization and refinement of poly N-butyl cyanoacrylate microbubbles for ultrasound imaging. Ultrasound Med Biol. 2011;37:1622–34.
pubmed: 21924206
doi: 10.1016/j.ultrasmedbio.2011.07.001
Joseph S, Gronewold TMA, Schlensog MD, Olbrich C, Quandt E, Famulok M, Schirner M. Specific targeting of ultrasound contrast agent (USCA) for diagnostic application: an in vitro feasibility study based on SAW biosensor. Biosens Bioelectron. 2005;20:1829–35.
pubmed: 15681200
doi: 10.1016/j.bios.2004.07.014
Ojha T, Pathak V, Drude N, Weiler M, Rommel D, Rütten S, Geinitz B, van Steenbergen MJ, Storm G, Kiessling F, Lammers T. Shelf-Life evaluation and lyophilization of PBCA-Based polymeric microbubbles. Pharmaceutics. 2019;11:433.
pubmed: 31454967
pmcid: 6781551
doi: 10.3390/pharmaceutics11090433
Fokong S, Theek B, Wu Z, Koczera P, Appold L, Jorge S, Resch-Genger U, van Zandvoort M, Storm G, Kiessling F, Lammers T. Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. J Controlled Release. 2012;163:75–81.
doi: 10.1016/j.jconrel.2012.05.007
Ríhová B, Jelínková M, Strohalm J, Subr V, Plocová D, Hovorka O, Novák M, Plundrová D, Germano Y, Ulbrich K. Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab’)(2)-targeted conjugates and combined therapy with immunomodulators. J Control Release. 2000;64:241–61.
pubmed: 10640661
Theek B, Baues M, Gremse F, Pola R, Pechar M, Negwer I, Koynov K, Weber B, Barz M, Jahnen-Dechent W, Storm G, Kiessling F, Lammers T. Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors. J Control Release. 2018;282:25–34.
pubmed: 29730154
pmcid: 6130770
doi: 10.1016/j.jconrel.2018.05.002
Slavenburg S, Huntjens-Fleuren HW, Dofferhoff TS, Richter C, Koopmans PP, Verwey-Van Wissen CP, Drenth JP, Burger DM. Ribavirin plasma concentration measurements in patients with hepatitis C: early Ribavirin concentrations predict steady-state concentrations. Ther Drug Monit. 2011;33:40–4.
pubmed: 21191316
doi: 10.1097/FTD.0b013e318205f892
Homma M, Jayewardene AL, Gambertoglio J, Aweeka F. High-performance liquid chromatographic determination of Ribavirin in whole blood to assess disposition in erythrocytes. Antimicrob Agents Chemother. 1999;43:2716–9.
pubmed: 10543752
pmcid: 89548
doi: 10.1128/AAC.43.11.2716
Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O’Farrell FM, Buchan AM, Lauritzen M, Attwell D. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508:55–60.
pubmed: 24670647
pmcid: 3976267
doi: 10.1038/nature13165
Tsai CJ, Nagata T, Liu CY, Suganuma T, Kanda T, Miyazaki T, Liu K, Saitoh T, Nagase H, Lazarus M, Vogt KE, Yanagisawa M, Hayashi Y. Cerebral capillary blood flow upsurge during REM sleep is mediated by A2a receptors. Cell Rep. 2021;36:109558.
pubmed: 34407410
doi: 10.1016/j.celrep.2021.109558
Itoh Y, Suzuki N. Control of brain capillary blood flow. J Cereb Blood Flow Metab. 2012;32:1167–76.
pubmed: 22293984
pmcid: 3390803
doi: 10.1038/jcbfm.2012.5
Buckley AG, Looi K, Iosifidis T, Ling K-M, Sutanto EN, Martinovich KM, Kicic-Starcevich E, Garratt LW, Shaw NC, Lannigan FJ, Larcombe AN, Zosky G, Knight DA, Rigby PJ, Kicic A, Stick SM. Visualisation of multiple tight junctional complexes in human airway epithelial cells. Biol Procedures Online. 2018;20:3.
doi: 10.1186/s12575-018-0070-0
Armulik A, Genové G, Betsholtz C. Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21:193–215.
pubmed: 21839917
doi: 10.1016/j.devcel.2011.07.001
Lertkiatmongkol P, Liao D, Mei H, Hu Y, Newman PJ. Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol. 2016;23:253–9.
pubmed: 27055047
pmcid: 4986701
doi: 10.1097/MOH.0000000000000239
Crouch EE, Doetsch F. FACS isolation of endothelial cells and pericytes from mouse brain microregions. Nat Protoc. 2018;13:738–51.
pubmed: 29565899
doi: 10.1038/nprot.2017.158
Remesar MC, Blejer JL, Weissenbacher MC, Nejamkis MR. Ribavirin effect on experimental Junin virus-induced encephalitis. J Med Virol. 1988;26:79–84.
pubmed: 2846772
doi: 10.1002/jmv.1890260111
Bendayan R, Ronaldson PT, Gingras D, Bendayan M. In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem. 2006;54:1159–67.
pubmed: 16801529
pmcid: 3957801
doi: 10.1369/jhc.5A6870.2006
Muendoerfer M, Schaefer UF, Koenig P, Walk JS, Loos P, Balbach S, Eichinger T, Lehr C-M. Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing. Int J Pharm. 2010;392:134–40.
pubmed: 20347022
doi: 10.1016/j.ijpharm.2010.03.046
Burgess A, Shah K, Hough O, Hynynen K. Focused ultrasound-mediated drug delivery through the blood-brain barrier. Expert Rev Neurother. 2015;15:477–91.
pubmed: 25936845
pmcid: 4702264
doi: 10.1586/14737175.2015.1028369
Abrahao A, Meng Y, Llinas M, Huang Y, Hamani C, Mainprize T, Aubert I, Heyn C, Black SE, Hynynen K, Lipsman N, Zinman L. First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound. Nat Commun. 2019;10:4373.
pubmed: 31558719
pmcid: 6763482
doi: 10.1038/s41467-019-12426-9
Mainprize T, Lipsman N, Huang Y, Meng Y, Bethune A, Ironside S, Heyn C, Alkins R, Trudeau M, Sahgal A, Perry J, Hynynen K. Blood-brain barrier opening in primary brain tumors with non-invasive MR-Guided focused Ultrasound: a clinical safety and feasibility study. Sci Rep. 2019;9:321.
pubmed: 30674905
pmcid: 6344541
doi: 10.1038/s41598-018-36340-0
Pathak V, Nolte T, Rama E, Rix A, Dadfar SM, Paefgen V, Banala S, Buhl EM, Weiler M, Schulz V, Lammers T, Kiessling F. Molecular magnetic resonance imaging of Alpha-v-Beta-3 integrin expression in tumors with ultrasound microbubbles. Biomaterials. 2021;275:120896.
pubmed: 34090049
doi: 10.1016/j.biomaterials.2021.120896
Idbaih A, Canney M, Belin L, Desseaux C, Vignot A, Bouchoux G, Asquier N, Law-Ye B, Leclercq D, Bissery A, De Rycke Y, Trosch C, Capelle L, Sanson M, Hoang-Xuan K, Dehais C, Houillier C, Laigle-Donadey F, Mathon B, André A, Lafon C, Chapelon JY, Delattre JY, Carpentier A. Safety and feasibility of repeated and transient blood-brain barrier disruption by Pulsed Ultrasound in patients with recurrent glioblastoma. Clin Cancer Res. 2019;25:3793–801.
pubmed: 30890548
doi: 10.1158/1078-0432.CCR-18-3643